Free Republic

New Delhi [India], September 24 (ANI): Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients. However, the new guidelines mention the use of Remdesivir and Tocilizumab in specific circumstances. Among the key guidelines which are routinely stressed include--wearing masks, physical distancing and hand hygiene. Suggesting a moderate use of other drugs like Remedesivir, the guideline advises the former to be used only in select moderate or severe Covid-19 patients on supplemental oxygen within 10 days of onset...

A recent case-controlled study by Indian Council of Medical Research (ICMR) has underlined the benefit of hydroxychloroquine (HCQ) as prophylaxis, showing that the sustained use of the anti-malaria drug along with the use of personal protective equipment (PPE) was associated with a significant decline in risk of Covid-19 infection rate by upto 80% among the health care workers. A recent case-controlled study by ICMR has underlined the benefit of hydroxychloroquine (HCQ) as prophylaxis, showing that the sustained use of the anti-malaria drug along with the use of personal protective equipment (PPE) was associated with a significant decline in risk of...